Fresenius Medical Care Renal Therapies Group, LLC has initiated a voluntary recall of all Crit-Line blood chambers, due to reports of leaks in some of the products. The recall involves more than 22 ...
WALTHAM, Mass., July 27, 2022 /PRNewswire/ -- Fresenius Medical Care North America's (FMCNA) Renal Therapies Group today announced the availability of the CombiSet SMARTECHTM, the first available ...
WALTHAM, Mass.-- (BUSINESS WIRE)--Fresenius Renal Therapies, a division of Fresenius Medical Care North America (FMCNA), the leading provider of products and services for the chronic kidney disease ...
Fresenius Medical Care has acquired all assets of Hema Metrics LLC related to its Crit-Line system for an undisclosed amount. The deal includes all assets related to blood monitoring systems and the ...
WALTHAM, Mass., Oct. 26, 2018 /PRNewswire/ -- Fresenius Medical Care's Renal Therapies Group today announced the results of four studies utilizing the Crit-Line ® monitor that examine how relative ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
WALTHAM, Mass., March 14, 2019 /PRNewswire/ -- Fresenius Medical Care North America's Renal Therapies Group, the leading provider of kidney care products, announced today that the U.S. Food and Drug ...